Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature.

Anna Theodorou-Kanakari, Spyridon Karampitianis, Vasiliki Karageorgou, Eleni Kampourelli, Efstathios Kapasakis, Panagiotis Theodossiadis, Irini Chatziralli

Journal: Advances in therapy 2019;35(10):1510-1518

PMID: 30173326

Free Full Text on PubMed Central View on PubMed

Abstract

INTRODUCTION

The purpose of this review is to present the current and emerging treatment alternatives for Leber's hereditary optic neuropathy (LHON), emphasizing the most recent use of idebenone and stem cells or gene therapy.

METHODS

A comprehensive literature review was performed at the PubMed database regarding the various treatment modalities for LHON.

RESULTS

Treatment modalities for LHON include nutritional supplements, activators of mitochondrial biogenesis, brimonidine, and symptomatic and supportive treatment, but nowadays attention is being paid to idebenone and gene therapy or stem cells.

CONCLUSION

The treatment of LHON remains challenging, given the nature of the disease and its prognosis.

Address: Medical School, National and Kapodistrian University of Athens, Athens, Greece.; 2nd Department of Ophthalmology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.; 2nd Department of Ophthalmology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece. [email protected].

DOI: 10.1007/s12325-018-0776-z